Dennis Bastas
Overview
Dennis Bastas is an Australian healthcare entrepreneur and investor with extensive experience in pharmaceuticals, consumer health, and pharmacy retailing. He is the Executive Chairman and CEO of DBG Health, Australia's largest diversified pharmaceutical, health, and beauty products business. In 2015, he acquired Arrow Pharmaceuticals from Aspen and merged it with Apotex Australia in 2019 to form Arrotex Pharmaceuticals. In 2023, he acquired full ownership of Arrotex Pharmaceuticals, Juno Pharmaceuticals, and Axe Health, consolidating them into DBG Health. Additionally, Bastas is the founder and Executive Chairman of myDNA, a leading pharmacogenomic and health genomic platform company. Under his leadership, myDNA has expanded its portfolio, including the acquisition of Sam Wood's fitness program in a $71 million deal in 2022. His strategic vision has significantly contributed to the growth and diversification of his ventures. Bastas' entrepreneurial journey reflects a commitment to innovation and excellence in the healthcare sector, positioning him as a prominent figure in Australia's pharmaceutical and health industries. His leadership continues to drive the success and expansion of DBG Health and myDNA, reinforcing his reputation as a key player in the global healthcare landscape.
Investment Focus
- Proven track record in the healthcare sector
- Innovative business models
- Scalable growth potential
- Strong management teams
- Alignment with health and wellness trends
- Commitment to quality and compliance
- Ability to expand into international markets
- Focus on consumer-centric solutions
- Technological integration in healthcare
- Sustainable and ethical business practices
- Clear exit strategies
- Competitive market positioning
- Strong intellectual property portfolio
- Demonstrated financial performance
- Positive social impact
Portfolio Companies
Get the full list of 54,000+ investors
Dennis Bastas and every other firm and angel in the database — as one spreadsheet you keep.
$19one-time payment · no subscription- All 54,000+ investors — VC firms, private equity, family offices and angels
- The key person to contact at each one, with their job title
- Their work email address
- Their phone number
- Their LinkedIn profile
- Delivered as a single .xlsx file — download it as many times as you like
Every profile on this site is one row of the file, with the contact details masked — browse a few before you buy.
Frequently asked questions about Dennis Bastas
What sectors does Dennis Bastas invest in?
Dennis Bastas invests in Technology, Consumer Goods, Retail, E-commerce, Healthcare Services and Digital Health, and is based in Australia. Dennis Bastas is listed as a angel investor in the ConnectSafely investor database.
What stage does Dennis Bastas invest at?
Dennis Bastas backs companies at Growth, Late Stage, Pre-IPO and Buyout.
Which regions does Dennis Bastas invest in?
Dennis Bastas invests across United States and Australia.
What companies has Dennis Bastas invested in?
Dennis Bastas's portfolio includes myDNA, DBG Health, Arrotex Pharmaceuticals, Juno Pharmaceuticals, Axe Health, MCoBeauty, Nude by Nature and PONi Cosmetics.
Last updated · Source: ConnectSafely investor database
